Coffin–Lowry syndrome (CLS) is an X-linked semi-dominant condition with learning difficulties and dysmorphism caused by mutations in the gene RSK2. Originally, epilepsy was reported as a feature. We and others have since described predominantly sound-startle induced drop attacks that have been labelled ‘cataplexy’, abnormal startle response and hyperekplexia. We sought to clarify why there should be controversy over the type of paroxysmal events. Review of the literature and our patients confirmed that each centre had studied only a small numbers of individuals (mean=2). The type of movement disorder varied both with age and between individuals. One individual might have more than one movement disorder. One of our adult patients had several types of movement disorder and epilepsy that merged seamlessly: there was true cataplexy triggered by telling a joke, something close to cataplexy (‘cataplexy’) triggered by sound-startle, a predominantly hypertonic reaction varying from hyperekplexia to a more prolonged tonic reaction resembling startle epilepsy, and true unprovoked epileptic seizures. In the large database of the Coffin–Lowry Syndrome Foundation family support group, 34 of 170 (20%) individuals with CLS and known age had ‘drop attacks’ and an additional 9 (5%) of these had additional epileptic seizures. The onset of such events was usually after age 5 years, prevalence peaking at 15–20 years (27%). Many became wheelchair bound as a result. This unique combination of more than one non-epileptic movement disorder and epilepsy deserves further semiological and genetic study both for the patients with CLS and for the wider implications.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Brain and Development
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Expression analysis of RSK gene family members: the RSK2 gene, mutated in Coffin–Lowry syndrome, is prominently expressed in brain structures essential for cognitive function and learning.Hum Mol Genet. 2002; 11: 2929-2940
- The Coffin syndrome.Hum Genet. 1977; 36: 271-276
- The radiology of Coffin–Lowry syndrome.Br J Radiol. 1990; 63: 72-75
- ‘Cataplexy’ and muscle ultrasound abnormalities in Coffin–Lowry syndrome.J Med Genet. 1998; 35: 94-98
- Cataplexy in Coffin Lowry Syndrome.Eur J Paediatr Neurol. 1997; 1: A25
- Hyperexplexia in Coffin–Lowry syndrome.Ann Neurol. 1997; 42: 505
- Drop episodes in Coffin–Lowry syndrome: exaggerated startle responses treated with clonazepam.Pediatr Neurol. 1998; 19: 148-150
- ‘Cataplexy’ in Coffin–Lowry syndrome.J Med Genet. 1998; 35: 702
- A female with Coffin–Lowry syndrome and ‘cataplexy’.Genet Couns. 2002; 13: 405-409
- Drop episodes in Coffin–Lowry syndrome: an unusual type of startle response.Epileptic Disord. 2000; 2: 173-176
- More than cataplexy in Coffin–Lowry syndrome: tonic as well as atonic semiology in sound-startle collapse.Dev Med Child Neurol. 1999; 28: 28
- Coffin–Lowry syndrome: a 20-year follow-up and review of long-term outcomes.Am J Med Genet. 2002; 111: 345-355
- Stimulus-induced drop episodes in Coffin–Lowry syndrome.Pediatrics. 2003; 111: e197-e202
- Validation of a cataplexy questionnaire in 983 sleep-disorders patients.Sleep. 1999; 22: 77-87
- Startle provoked epileptic seizures: features in 19 patients.J Neurol Neurosurg Psychiatry. 1996; 61: 151-156
- Mutations in the X-linked RSK2 gene (RPS6KA3) in patients with Coffin–Lowry syndrome.Hum Mutat. 2001; 17: 103-116
Accepted: November 12, 2003
Received in revised form: November 12, 2003
Received: July 14, 2003
☆The paper is based on the lecture given at the sixth annual meeting of the Infantile Seizure Society, Tokyo, March 15–16, 2003.
© 2004 Elsevier B.V. Published by Elsevier Inc. All rights reserved.